TOPSHOT - Russian tennis player Maria Sharapova speaks at a press conference in downtown Los Angeles, California, March 7, 2016. The former world number one announced she failed a doping test at the Australian Open, saying a change in the World-Anti-Doping Agency banned list led to the violation. Sharapova said she tested positive for Meldonium, a substance she had been taking since 2006 but one that was added to the banned list this year. / AFP / ROBYN BECK (Photo credit should read ROBYN BECK/AFP/Getty Images)

Maria Sharapova has filed an appeal to the Court of Arbitration for Sport seeking to annul or reduce her two-year suspension for a failed drug test at the Australian Open in January. The parties have agreed to an expedited track for the case, which will allow CAS to issue its decision no later than July 18th, 2016.

Last week, an independent tribunal appointed by the International Tennis Federation found that Sharapova committed an Anti-Doping Rule Violation, and imposed a period of ineligibility of two years. Under the tribunal’s decision, Sharapova would be allowed to return on January 27, 2018.

 

Maria Sharapova ha presentado su apelacion a la corte de arbitraje del deporte CAS, buscando anular o al menos reducir la sancion de 2 años aplicada por no superar los examenes antidrogas durante el abierto de Australia a comienzos de año. las partes fijaron una fecha, no mas tarde del 18 de julio del 2016 para conocer una decision.

La semana pasada un tribunal independiente de la Federacion Internacional de Tenis encontro a Sharapova cumplable de violar las reglas antidoping y le aplico una sancion de 2 años, hasta que no se conozca la decision de la apelacion, Sharapova no podra jugar tenis profesional hasta el 27 de enero del 2018.